AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
299 hedge funds and large institutions have $2.74B invested in Amedisys in 2023 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 86 increasing their positions, 107 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4.65% less ownership
Funds ownership: 96.6% → 91.95% (-4.7%)
20% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 107
25% less call options, than puts
Call options by funds: $17.8M | Put options by funds: $23.8M
Holders
299
Holding in Top 10
2
Calls
$17.8M
Puts
$23.8M
Top Buyers
| 1 | +$64.5M | |
| 2 | +$51.1M | |
| 3 | +$44.2M | |
| 4 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$40.1M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$30.8M |
Top Sellers
| 1 | -$92.9M | |
| 2 | -$82.4M | |
| 3 | -$44.6M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$42M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$32.8M |